Should levetiracetam rather than phenobarbitone be the first-line treatment for neonatal seizures?

A male infant was born at 39 weeks’ gestation by spontaneous vaginal delivery. The mother was a 32-year-old primigravida. Antenatal course was uneventful. Apgar score was 9 at 1 min and 10 and 5 min. He did not require resuscitation and was transferred to the postnatal ward with the mother. At 30 hours of age, he developed right arm and leg jerking. A bedside cranial ultrasound suggested a left middle-cerebral artery territory infarct. Given the frequent use of levetiracetam in paediatric seizures with a good effect, should this drug be used as first-line in the treatment of neonatal seizures? 1. In neonates diagnosed with seizures, is there evidence to support levetiracetam rather than phenobarbitone as the first-line treatment of neonatal seizures? ### Primary sources MEDLINE, PubMed, Embase and TRIP were searched using the following search terms: ( Neonat* [neonate, neonates, neonatal] OR newborn ) AND ( Levetiracetam OR Keppra) AND (Seizure OR epilepsy OR convulsion ) ( Neonat* [neonate, neonates, neonatal] OR newborn AND (Phenobarb [phenobarbitone, phenobarbital]) AND ( Seizure OR epilepsy OR convulsion ) ### Secondary sources The Cochrane Library was searched using a combination of the terms as …

[1]  R. Raman,et al.  Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial , 2020, Pediatrics.

[2]  Li Jiang,et al.  Efficacy and safety of levetiracetam in the off-label treatment of neonatal seizures , 2020, The International journal of neuroscience.

[3]  D. Licht,et al.  A retrospective comparison of phenobarbital and levetiracetam for the treatment of seizures following cardiac surgery in neonates , 2020, Epilepsia.

[4]  R. Shellhaas,et al.  Acute Symptomatic Seizures in Neonates. , 2019, Seminars in pediatric neurology.

[5]  Vykuntaraju K Gowda,et al.  Levetiracetam versus Phenobarbitone in Neonatal Seizures — A Randomized Controlled Trial , 2019, Indian Pediatrics.

[6]  Margie A. Ream,et al.  Status Epilepticus in the Neonate: Updates in Treatment Strategies , 2019, Current Treatment Options in Neurology.

[7]  Shaun A. Hussain,et al.  A comparison of levetiracetam and phenobarbital for the treatment of neonatal seizures associated with hypoxic–ischemic encephalopathy , 2018, Epilepsy & Behavior.

[8]  L. Manganas,et al.  A Systematic Review of the Efficacy of Levetiracetam in Neonatal Seizures , 2017, Neuropediatrics.

[9]  J. Soul,et al.  The use of phenobarbital and other anti-seizure drugs in newborns. , 2017, Seminars in fetal & neonatal medicine.

[10]  B. Griffin,et al.  Pharmacotherapy for Neonatal Seizures: Current Knowledge and Future Perspectives , 2016, Drugs.

[11]  S. Kadam,et al.  Neonatal Seizures: Impact on Neurodevelopmental Outcomes , 2015, Front. Pediatr..

[12]  G B Boylan,et al.  Defining the gap between electrographic seizure burden, clinical expression and staff recognition of neonatal seizures , 2007, Archives of Disease in Childhood Fetal and Neonatal Edition.